ABU DHABI / GULF TIME In a groundbreaking moment for luxury real estate, the German ...
Read More »Novartis starts sale of ophthalmology assets
BLOOMBERG Novartis AG is kicking off the sale of some ophthalmology assets, people with knowledge of the matter said, as it seeks to prune its portfolio and focus on growth areas. The Swiss pharmaceuticals group is working with an adviser to gauge interest in the so-called front-of-eye treatments, the people said. The portfolio includes Xiidra, a drug used to treat ...
Read More »